ConductScience.org, home

Paper28964591

A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.

Glaze DG and 10 others. Pediatr Neurol, 2017. Cited by 81 papers, by iCite.

Cite this record

ConductScience Library. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome. Papers, record 28964591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28964591

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
PubMed
Journal
Pediatr Neurol
PubMed
Year
2017
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
3.36
iCite
Revised in PubMed
2026-01-27
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glaze DGDaniel G
2Neul JLJeffrey L
3Percy AAlan
4Feyma TTim
5Beisang AArthur
6Yaroshinsky AAlex
7Stoms GGeorge
8Zuchero DDavid
9Horrigan JJoseph
10Glass LLarry
11Jones NENancy E

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neuroprotective AgentsMajor topic
OligopeptidesMajor topic
Rett SyndromeMajor topic
Adolescent
Adult
Female
Humans
Male
Young Adult
Cohort Studies
Dose-Response Relationship, Drug
Double-Blind Method
Treatment Outcome
Glutamates

Source PubMed

Download CSV of topics

Cited by63

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
42577214Characteristics of adult individuals with Rett syndrome treated or untreated with trofinetide in the United States.Front Neurol2026https://conductscience.org/library/papers/42577214PubMed
42563928Expert Consensus on Real-World Use of Trofinetide for Rett Syndrome Using a Modified Delphi Method.Ann Child Neurol Soc2026https://conductscience.org/library/papers/42563928PubMed
42530159Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi-Stage Computational Analysis.J Comput Chem2026https://conductscience.org/library/papers/42530159PubMed
42383019Minimum data requirements and automated preprocessing for reliable EEG biomarkers in Rett syndrome.Front Neurol2026https://conductscience.org/library/papers/42383019PubMed
42111068Clinical experience using trofinetide in Rett syndrome and related MECP2 diagnosis at the children's hospital of Philadelphia post approval.Front Neurol2026https://conductscience.org/library/papers/42111068PubMed
41501636Longitudinal Rett syndrome behaviour questionnaire scores and their associations with genotype and trajectories of mobility, weight and seizure frequency status.J Neurodev Disord2026https://conductscience.org/library/papers/41501636PubMed
40882535Natural history of epilepsy in FOXG1 Syndrome.Epilepsy Res2025https://conductscience.org/library/papers/40882535PubMed
40880843Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries.Ann Child Neurol Soc2025https://conductscience.org/library/papers/40880843PubMed
40595330AI-enabled drug prediction and gene network analysis reveal therapeutic use of vorinostat for Rett Syndrome in preclinical models.Commun Med (Lond)2025https://conductscience.org/library/papers/40595330PubMed
40138183A Blueprint for Translational Precision Medicine in Autism Spectrum Disorder and Related Neurogenetic Syndromes.J Child Adolesc Psychopharmacol2025https://conductscience.org/library/papers/40138183PubMed
39709426International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA.Trials2024https://conductscience.org/library/papers/39709426PubMed
39692836Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome.Adv Ther2025https://conductscience.org/library/papers/39692836PubMed
39669590Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).Genet Med Open2024https://conductscience.org/library/papers/39669590PubMed
39641900Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis.Curr Neurol Neurosci Rep2024https://conductscience.org/library/papers/39641900PubMed
39525048Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy.Drug Des Devel Ther2024https://conductscience.org/library/papers/39525048PubMed
39516357Physiologically-Based Pharmacokinetic Modeling of Trofinetide in Moderate Renal Impairment for Phase 1 Clinical Study Dose Selection with Model Validation.Eur J Drug Metab Pharmacokinet2025https://conductscience.org/library/papers/39516357PubMed
39455915Associations between genotype, phenotype and behaviours measured by the Rett syndrome behaviour questionnaire in Rett syndrome.J Neurodev Disord2024https://conductscience.org/library/papers/39455915PubMed
39440617Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities.Ann Clin Transl Neurol2024https://conductscience.org/library/papers/39440617PubMed
39251501Rett Syndrome: The Emerging Landscape of Treatment Strategies.CNS Drugs2024https://conductscience.org/library/papers/39251501PubMed
39020317Is trofinetide a future treatment for Rett syndrome? A comprehensive systematic review and meta-analysis of randomized controlled trials.BMC Med2024https://conductscience.org/library/papers/39020317PubMed

See all 63 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28964591

GET https://conductscience.org/api/papers/v1/28964591/cited_by?page=2